Health product recall

Jamp-Metformin Product Recall (2020-03-10)

Starting date:
March 10, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-72565

Last updated: 2020-03-12

Summary

  • Product:
    A. Jamp-Metformin 500 mg tablet   

    B. Jamp-Metformin 850 mg tablet

A. Jamp-Metformin 500 mg tablet  

B. Jamp-Metformin 850 mg tablet

Reason

Affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.

Depth of distribution

Retailers

Affected products

A. Jamp-Metformin 500 mg tablet

DIN, NPN, DIN-HIM

DIN 02380196

Dosage form

tablet

Strength

Metformin hydrochloride 500 mg

Lot or serial number

X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580

Companies

Recalling Firm

JAMP Pharma Corporation

1310 Nobel Street

Boucherville

J4B 5H3

Quebec

CANADA

Marketing Authorization Holder

JAMP Pharma Corporation

1310 Nobel Street

Boucherville

J4B 5H3

Quebec

CANADA

B. Jamp-Metformin 850 mg tablet

DIN, NPN, DIN-HIM

DIN 02380218

Dosage form

tablet

Strength

Metformin hydrochloride 850 mg

Lot or serial number

X20385, X20386, X19224, X19225, X19226

Companies

Recalling Firm

JAMP Pharma Corporation

1310 Nobel Street

Boucherville

J4B 5H3

Quebec

CANADA

Marketing Authorization Holder

JAMP Pharma Corporation

1310 Nobel Street

Boucherville

J4B 5H3

Quebec

CANADA